Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01321424 · ClinicalTrials.gov registry record
Diurnal Variation in Tear Osmolarity
A clinical trial, sponsored by Ophthalmic Consultants of Long Island.
- Completed
- Registry status
- 60
- Enrollment target
NCT01321424: Completed study, sponsored by Ophthalmic Consultants of Long Island.
NCT01321424 is a clinical trial that has completed, run by Ophthalmic Consultants of Long Island. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01321424 has completed, sponsored by Ophthalmic Consultants of Long Island.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the change in Tear Osmolarity during the course of the day to support clinical diagnosis of aqueous deficiency or meibomian gland disease and differentiate between the two forms of dry eye.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-03 |
| Est. Completion | 2016-03 |
What the finished NCT01321424 record still lists
NCT01321424 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01321424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01321424 about?
NCT01321424 is a clinical study titled "Diurnal Variation in Tear Osmolarity". The purpose of this study is to measure the change in Tear Osmolarity during the course of the day to support clinical diagnosis of aqueous deficiency or meibomian gland disease and differentiate between the two forms of dry eye.
What is the current status of trial NCT01321424?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2011-03. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT01321424?
This trial is sponsored by Ophthalmic Consultants of Long Island, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia